Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-13T16:50:24.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page no longer lists the Study Documents and related metadata such as the Statistical Analysis Plan and Study Protocol, along with associated provider and publications details. This reduces access to supplementary materials for the NCT02638103 HALO study while keeping the main study overview intact.
    Difference
    18%
    Check dated 2026-09-22T20:56:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, signaling a newer version of the ClinicalTrials.gov page. This appears to reflect internal updates or maintenance rather than a substantive change to study details or publicly visible content.
    Difference
    0.0%
    Check dated 2026-09-15T21:35:39.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This appears to be a minor maintenance update to the page's revision history and does not alter core content like study details or eligibility.
    Difference
    0.0%
    Check dated 2026-09-01T18:08:08.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    An NIH funding attribution line '2015 ( U.S. NIH Grant/Contract )' has been added to the study's identifiers section. This addition records funding information for the study but does not change the study design, eligibility, or reported outcomes.
    Difference
    0.0%
    Check dated 2026-08-25T16:37:04.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a newer build of the page. This update likely represents minor maintenance or polish without altering study content.
    Difference
    0.0%
    Check dated 2026-08-11T08:14:04.000Z thumbnail image

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.